Success Stories: NAILG Supported an Associate Research Scientist in the Field of Biochemistry in Securing an NIW Petition Approval
Client’s Testimonial:
“This is wonderful news! Thank you so much for letting me know!”
On July 19th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Research Scientist in the Field of Biochemistry (Approval Notice).
General Field: Biochemistry
Position at the Time of Case Filing: Associate Research Scientist
Country of Origin: Germany
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: July 19th, 2023
Processing Time: 29 days (Premium Processing Requested)
Case Summary:
A distinguished biochemist specializing in epigenetics approached our legal team for assistance with his National Interest Waiver (NIW) petition. We conducted a thorough assessment of his academic credentials and research achievements, verifying the depth and significance of his contributions to genetic disease research. Confident in the importance of his work, we proceeded with the retainer agreement to secure his NIW approval.
Our client’s research is dedicated to unraveling the structural basis of epigenetic modifiers, paving the way for innovative therapeutic interventions for genetic disorders. His key contributions include:
- Authorship of 14 peer-reviewed journal articles, with one as the first author and two as co-first author.
- A total of 1,097 citations reflects the broad recognition and influence of his research.
- Significant funding support from leading institutions, including the National Institutes of Health (NIH), the United Kingdom’s Biotechnology and Biological Sciences Research Council (BBSRC), and the State of São Paulo Research Foundation (FAPESP), among others.
His work has significantly deepened our understanding of epigenetic regulation, with far-reaching implications for the development of novel therapeutic approaches. Given his impressive track record and continued dedication, it is evident that he will remain at the forefront of biomedical advancements.
He even received 4 letters of recommendation from fellow experts, one of the excerpts is mentioned below:
“To conclude, [client] is a major player in the biotechnologies field, and I propose an innovative investigator with strong expertise in biotechnology. His mastery of both classic biochemical techniques and modern, state-of-the-art approaches for genomics, transcriptomics, and proteomics analysis makes him a significant asset to the United States. I acknowledge that he is an advantage in the maintenance of the country’s global leadership. Thank you.”
Through our meticulous and strategic case preparation, we effectively demonstrated the national significance of the client’s research, leading to his successful NIW approval. His achievements underscore the transformative impact of scientific innovation on healthcare, and we are honored to have played a role in his journey. We look forward to witnessing his ongoing contributions to biomedical science and epigenetics.